# US 2017/0370919 A1 · Methods and compositions relating to small molecule analyte assays

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2017/0370919 A1
- Document ID: US20170370919A1
- Status: Published application
- Kind: A1
- Application number: 15/633,212
- Filed: 2017-06-26
- Published: 2017-12-28
- Earliest claimed: 2016-06-24
- Assignees: Arbor Assays LLC
- Applicants: Arbor Assays LLC
- Inventors: Russell Hart
- Web page: https://patentgrep.com/patent/US20170370919A1

## CPC

- G01N 33/54306: {Solid-phase reaction mechanisms}
- G01N 33/5308: {for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites}
- G01N 33/581: {with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates)}
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

Kits and methods according to aspects of the present invention relate to the detection and quantitation of small molecule analytes including 8-hydroxyguanosine, 8-hydroxyguanine, and 8-hydroxy-2′-deoxyguanosine.

## Claims

### Claim 1

A method for detecting a small molecule analyte in a sample, comprising:
providing a first component comprising a receptor, wherein the first component is immobilized on a solid phase support, and wherein the receptor does not specifically bind to the small molecule analyte;
providing a second component comprising a ligand for said receptor, said ligand conjugated to a conjugated small molecule analyte;
providing a third component comprising a detection molecule conjugated to a label, the detection molecule capable of specific binding with the small molecule analyte, wherein said third component does not specifically bind to the first component;
contacting the second component and the immobilized first component under specific binding reaction conditions, whereby the second component is immobilized on the solid phase support by specific binding of the receptor and the ligand, producing an immobilized second component;
contacting a fluid sample containing or suspected of containing the small molecule analyte and the immobilized second component with the third component under specific binding reaction conditions, whereby a labeled immobilized complex is formed between the third component and the immobilized second component by the binding between the detection molecule and the conjugated small molecule analyte, and whereby a labeled non-immobilized complex is formed between the third component and the small molecule analyte of the fluid sample by specific binding between the detection molecule and the small molecule analyte of the fluid sample;
separating the immobilized complex from the non-immobilized complex; and
detecting a signal from the labeled immobilized complex, the labeled non-immobilized complex, or both the labeled immobilized complex and the labeled non-immobilized complex, thereby detecting the small molecule analyte in the sample.

### Claim 2 (depends on 1)

The method of claim 1, wherein the small molecule analyte is selected from the group consisting of: 8-hydroxyguanosine, 8-hydroxyguanine, 8-hydroxy-2′-deoxyguanosine, and two or more thereof.

### Claim 3 (depends on 1)

The method of claim 1, wherein the receptor is an antibody, a lectin, fibronectin, protein A, protein G, avidin, steptavidin, or two or more thereof.

### Claim 4 (depends on 1)

The method of claim 1, wherein the ligand comprises an antibody, a protein, a sugar, biotin, a biotin labeled protein, or two or more thereof.

### Claim 5 (depends on 1)

The method of claim 1, wherein the fluid sample is saliva, urine, plasma, serum, isolated DNA, isolated RNA, a cell lysate, a tissue sample lysate, cell culture medium, hair, feathers, a fecal sample, cerebrospinal fluid (CSF), milk, or two or more thereof.

### Claim 6 (depends on 1)

The method of claim 1, wherein the detection molecule is an antibody specific for the small molecule analyte.

### Claim 7 (depends on 1)

The method of claim 1, wherein contacting a fluid sample containing or suspected of containing the small molecule analyte with the immobilized second component is performed concurrently with contacting a fluid sample containing or suspected of containing the small molecule analyte with the third component.

### Claim 8 (depends on 1)

The method of claim 1, further comprising contacting the fluid sample with the first component, wherein the fluid sample is contacted with the first component prior to contacting the first component with the second component.

### Claim 9 (depends on 1)

The method of claim 1, further comprising quantitating the small molecule analyte in the sample, thereby determining an amount and/or concentration of the small molecule analyte in the sample.

### Claim 10 (depends on 9)

The method of claim 9, wherein quantitating the small molecule analyte in the sample comprises comparing the signal from the labeled immobilized complex, the labeled non-immobilized complex, or both the labeled immobilized complex and the labeled non-immobilized complex with a standard, the standard generated using a known amount of the small molecule analyte.

### Claim 11 (depends on 10)

The method of claim 10, wherein the standard is a standard curve.

### Claim 12

A kit for the detection of a small molecule analyte, the kit comprising:
a first component comprising a receptor;
a second component comprising a ligand for said receptor, said ligand conjugated to the small molecule analyte; and
a third component comprising a detection molecule conjugated to a label, the detection molecule capable of specific binding with the small molecule analyte.

### Claim 13 (depends on 12)

The kit of claim 12, wherein the first component is immobilized on a solid phase support.

### Claim 14 (depends on 13)

The kit of claim 13, wherein the second component is immobilized on the solid phase by the binding between the immobilized receptor and the ligand.

### Claim 15 (depends on 12)

The kit of claim 12, wherein the small molecule analyte is 8-hydroxyguanosine, 8-hydroxyguanine, 8-hydroxy-2′-deoxyguanosine, or two or more thereof.

### Claim 16 (depends on 12)

The kit of claim 12, wherein the receptor comprises an antibody, an antigen-binding portion of an antibody, a lectin, fibronectin, protein A, protein G, avidin, steptavidin, or two or more thereof; and the ligand comprises an antibody, an antigen-binding portion of an antibody, a sugar, gelatin, biotin, a biotin labeled protein, or two or more thereof wherein the ligand specifically binds to the receptor.

### Claim 17 (depends on 12)

The kit of claim 12, wherein the detection molecule is an antibody specific for 8-hydroxyguanosine, 8-hydroxyguanine, 8-hydroxy-2′-deoxyguanosine, an antigen-binding portion thereof, or two or more thereof.

### Claim 18

A method for detecting 8-hydroxy-2′-deoxyguanosine (8-HOdG) in a sample, comprising:
providing a first component comprising a receptor, wherein the first component is immobilized on a solid phase support, and the receptor does not specifically bind 8-HOdG;
providing a second component comprising a ligand for said receptor, said ligand conjugated to 8-HOdG such that the second component comprises ligand-conjugated 8-HOdG;
providing a third component comprising a detection molecule conjugated to a label, the detection molecule capable of specific binding with 8-HOdG, wherein the third component does not specifically bind to the first component;
contacting: 1) a fluid sample containing or suspected of containing 8-HOdG and 2) the immobilized first component;
contacting: 1) the second component and 2) the immobilized first component under specific binding reaction conditions, whereby the second component is immobilized on the solid phase support by specific binding of the receptor and the ligand, thereby producing an immobilized second component;
contacting a fluid sample and immobilized second component with the third component under specific binding reaction conditions, whereby an immobilized complex is formed between the third component and the immobilized second component by specific binding between the detection molecule and the ligand-conjugated 8-HOdG, and whereby a non-immobilized complex is formed between the third component and the 8-HOdG of the fluid sample by specific binding between the detection molecule and the 8-HOdG of the fluid sample;
separating the immobilized complex from the non-immobilized complex; and
detecting the label of the immobilized complex.

### Claim 19 (depends on 18)

The method of claim 18, wherein:
the receptor is an antibody;
the ligand is an antibody;
the detection molecule is an antibody;
the label is an enzyme, a peroxidase, or horseradish peroxidase; or
the method further comprises contacting the label with a substrate and detecting the label comprises detecting either the substrate or a product of the substrate.

### Claim 20 (depends on 18)

The method of claim 18, further comprising quantitating the 8-HOdG in the sample, thereby determining an amount and/or concentration of the 8-HOdG in the sample.
